Abstract
In September 1987, a cooperative clinical programme on the biological therapy of tumours, supported by the Italian government, was initiated. The project included a series of experimental and clinical studies, carried out at the Department of Medical Oncology I of the Regina Elena National Cancer Institute of Rome, partially in collaboration with the Laboratory of Haematology and Oncology of the Italian National Institute of Health and the Department of Haematology of “La Sapienza” University, Rome.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE: Observations on the systemic administration autologous lymphokine- activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985 (313):1485–1492
Atzpodien J, Korfer A, Franks CR, Poliwoda H, Kirchner H: Home therapy with recombinant lnterleukin-2 and lnterferon-a2b in advanced human malignancies. Lancet 1990 (335):1509–1513
Giannella G, Pelosi Testa E, Carlini P, Habetswallner D, Montesoro E, Camagna A: Fluctuations of plasma 2 microglobulin, soluble interleukin-2 receptor and interferon gamma concentrations after adoptive immunotherapy with high-dose interleukin-2 and lymphokine activated killer cells. Immunobiol 1989 (178):305–315
Boccoli G, Masciulli FR, Ruggeri EM, Carlini P, Giannella G, Montesoro E: Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high dose interleukin-2 bolus treatment. Cancer Res 1990 (50):5795–5800
West WH, Taner KW, Yannelli JR, Marshall GD, Douglas DW, Thurman GB: Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 1987 (316): 898–905
Scalzo S, Gengaro A, Boccoli G, Masciulli R, Giannella G, Salvo G: Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinoma. Eur J Cancer 1990 (26):1152–1156
Ruggeri EM, Calabresi F, Carlini P, Ceribelli A, Nardi M, Franks CR: Local intraarterial continuous infusion of interleukin-2 (rlL-2) in patients with hepatic metastases or hepatoma. A Phase I A-B study (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Calabresi, F., Ruggeri, E.M. (1992). Clinical Trials with Interleukin-2. The Rome Experience. In: Mertelsmann, R. (eds) Lymphohaematopoietic Growth Factors in Cancer Therapy II. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77801-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-77801-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77803-2
Online ISBN: 978-3-642-77801-8
eBook Packages: Springer Book Archive